Overview

Pharmacokinetics of Midazolam, With and Without Concomitant Administration of Crobenetine in Healthy Male Subjects

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the pharmacokinetics of midazolam with/without concomitant administration of crobenetine
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Midazolam